Gwangmyeong-Si, Gyeonggi-Do, South Korea

Primoris Therapeutics Co., Ltd.

Calculating rank

USPTO Granted Patents = 1

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Hee-Jin Ahn (1 out of 8 patents)

Dong-yeol Lee (1 out of 1 patent)

Jae-yong Lee (1 out of 1 patent)

4. Yea-In Lee (1 out of 1 patent)

5. Kyu-Heum Na (1 out of 1 patent)

1 patent: Sort by Forward Citations

1. 12723065 - METHOD FOR ISOLATING AND CULTURING CORD BLOOD STEM CELLS EXPRESSING GDF-3 AT HIGH LEVEL, AND USE OF GDF-3 (2026-09-01),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

1 Patents

#1,831 in GWANGMYEONG-SI, GYEONGGI-DO

#5,810 in South Korea

Gwangmyeong-Si, Gyeonggi-Do, South Korea

Primoris Therapeutics Co., Ltd.

Forward Citations = 0

5 inventors:

Hee-Jin Ahn (1 out of 8 patents)

Dong-yeol Lee (1 out of 1 patent)

Jae-yong Lee (1 out of 1 patent)

4. Yea-In Lee (1 out of 1 patent)

5. Kyu-Heum Na (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Primoris Therapeutics Co., Ltd.. Retrieved from https://idiyas.com/company/primoris-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]